Spine One-Year Outcomes Data from the OptiMesh® SCOUT (Spineology® Clinical Outcomes Trial) IDE (Investigational Device Exemption) Published in SPINE byJosh SandbergNovember 17, 2020
Spine Spineology Completes Enrollment in Post-Market Study of Novel, Expandable Lateral Implant byChris StewartOctober 5, 2020
Regulatory Spine Spineology® Announces FDA De Novo Grant of Minimally Invasive OptiMesh® Expandable Interbody Fusion System byChris StewartSeptember 21, 2020
Spine Unique Study Nominated for Best Paper at SMISS by Providing Rare Illustration of Patient-Reported Outcomes in Lateral Access Surgery byChris StewartNovember 5, 2019
Spine Spineology Mesh Interbody Fusion Technologies Yield Excellent/Good Patient Satisfaction Scores in Excess of 85 Percent byJosh SandbergApril 8, 2019
Spine Spineology Provides Duo™ System Commercial and Post-Market Update byJosh SandbergJanuary 8, 2019
